Erythropoietin-induced Treatment Costs in Patients Suffering from Renal Anemia -- A Comparison between Biosimilar and Originator Drugs.

Autor: Hörbrand, F., Rottenkolber, D., Fischaleck, J., Hasford, J.
Zdroj: Gesundheitswesen; 2014, Vol. 76 Issue 11, pe74-e84, 6p
Databáze: Complementary Index